SanBio Company Limited
Financial Results for the 2nd Quarter
of the Fiscal Year Ending January 31, 2024

Disclaimer
This presentation material, including any comments made during or following the presentation, is provided solely for the purpose of reference to those investors who make their own evaluation of the company at their own risk.
This material contains estimates, such as plans, strategies and judgements, that are forward-looking statements which are made based on management’s assumptions and beliefs in light of the information currently available to it and may contain risks and uncertainty. Therefore
you should not place undue reliance on them in making investment decisions.
SanBio cautions you that actual results may differ substantially from those discussed inthis material due to various factors.
We do not guarantee the accuracy or completeness of the information herein.
Unless otherwise stated. estimates or forecastsare solely those of our company and subject to change without notice.
We accept no liability whatsoever for any direct or consequential loss arising from any use of this report.
CEO Keita Mori
Senior Corporate Officer, responsible for HR,<br>Japan Regulatory Affairs & Quality Compliance Japan,<br>and Japan/Asia Business, Naoki Tsukahara